Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-28 · accession 0000950170-25-100320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-07-30 | 2025-07-28 | CADL | Nichols William Garrett | Chief Medical Off | M - OptEx | $1.29 | +937 | 53.4K | +2% | +$1,209 |
| DT | 2025-07-30 | 2025-07-28 | CADL | Nichols William Garrett | Chief Medical Off | S - Sale+OE | $6.98 | -937 | 52.5K | -2% | -$6,540 |
| DT | 2025-07-30 | 2025-07-28 | CADL | Nichols William Garrett | Chief Medical Off | M - OptEx | $0.00 | -937 | 29.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-28 | M | A | 937 | $1.29 | 53,430 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-28 | S | D | 937 | $6.98 | 52,493 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-07-28 | M | D | 937 | $0.00 | 29,377 | D | $1.29 · — to 2033-04-28 | 937 Common Stock | (F2) This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date. |